SciELO - Scientific Electronic Library Online

 
vol.10Análises cromossômicas no aconselhamento genético de pacientes com alterações no desenvolvimento e congênitas em Belém, estado do Pará, Brasil: um estudo retrospectivo de 17 anosPresencia de clones de hemoglobinuria paroxística nocturna en portadores de leucemia aguda del estado de Pará, Amazonía, Brasil índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Pan-Amazônica de Saúde

versión impresa ISSN 2176-6215versión On-line ISSN 2176-6223

Resumen

BAIA, Kássia do Socorro Moraes et al. Laboratory reevaluation of hepatitis C virus infection in patients undergoing dialysis treatment in the 1990s, in Belém, Pará State, Brazil. Rev Pan-Amaz Saude [online]. 2019, vol.10, e201901632.  Epub 20-Nov-2019. ISSN 2176-6215.  http://dx.doi.org/10.5123/s2176-6223201901632.

OBJECTIVE:

To describe aspects of laboratory serological and molecular diagnosis of hepatitis C virus (HCV) infection in patients undergoing treatment at a dialysis clinic in Belém, Pará State, Brazil, from 1990 to 1993.

MATERIALS AND METHODS:

Retrospective study for reassessment of serum samples from dialysed patients using serological tests for the detection of HCV (anti-HCV and Ag-Ab HCV) and HCV-RNA by molecular RT-PCR.

RESULTS:

A total of 115 dialysed patients with serum samples collected during the study period were included. Analysis of these samples showed a 16.5% prevalence of anti-HCV reagent, among which 4.3% showed an indicator of active viral replication (HCV-RNA reagent). Seroconversion rate was detected in 55.2% of patients in the analyzed period. The anti-HCV group, Ag-Ab HCV and HCV-RNA reagent were the most prevalent (41.7%). For non-reactive anti-HCV samples, viral replication with HCV-RNA reagent was 22.7%. Genotypes 1 and 3 were detected. Genotype 1 was prevalent in 73.0% of the samples.

CONCLUSION:

When laboratory screening for HCV (anti-HCV) was introduced in the dialysis clinic, it was possible to observe: high prevalence of HCV infection among patients under treatment; high rates of seroconversion; equation between serological results using second and third generation ELISA methods; presence of viral replication among nonreactive anti-HCV patients; and higher prevalence of HCV genotype 1.

Palabras clave : Hepatitis C Virus; Serological Tests; Hemodialysis.

        · resumen en Español | Portugués     · texto en Español | Portugués     · Español ( pdf ) | Portugués ( pdf )